Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지
DOI QR코드

DOI QR Code

Impact of Cytomegalovirus Disease on New-Onset Type 2 Diabetes Mellitus: Population-Based Matched Case-Control Cohort Study

  • Yoo, Seul Gi (Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Han, Kyung Do (Department of Biostatistics, College of Medicine, The Catholic University of Korea) ;
  • Lee, Kyoung Hwa (Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • La, Yeonju (Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Kwon, Da Eun (Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine) ;
  • Han, Sang Hoon (Division of Infectious Disease, Department of Internal Medicine, Yonsei University College of Medicine)
  • Received : 2018.08.29
  • Accepted : 2018.10.10
  • Published : 2019.12.30
⟨ Previous Next ⟩

Abstract

Background: A latent cytomegalovirus (CMV) cause chronic inflammation through undesirable inflation of cell-mediated immune response. CMV immunoglobulin G has been associated with cardiovascular disease and type 1 diabetes mellitus. We evaluated impact of CMV diseases on new-onset type 2 diabetes mellitus (T2DM). Methods: From the Korean Health Insurance Review and Assessment Service claim database of entire population with 50 million, we retrieved 576 adult case group with CMV diseases diagnosed with International Statistical Classification of Diseases and Related-Health Problems 10th Revision (ICD-10) B25 code between 2010 and 2014 after exclusion of patients with T2DM to 2006. The 2,880 control patients without T2DM from 2006 to cohort entry point were selected between 2010 and 2014 by age, sex matching with case group. The subjects without new-onset T2DM were followed until 2015. T2DM, hypertension (HTN), dyslipidemia (DYS), and end-stage renal disease (ESRD) were coded as ICD-10. Results: The frequency of new-onset T2DM in case group was significantly higher than that in control (5.6% vs. 2.2%, P<0.001). The group with T2DM (n=95) had higher incidence of CMV diseases than the group without T2DM (n=3,361) (33.7% vs. 16.2%, P<0.001). In multivariate regression model adjusted by age, sex, lower income, HTN, and DYS, the incidence rate (IR) of T2DM in case group was significantly higher than that in the control group (IR per 1,000, 19.0 vs. 7.3; odds ratio, 2.1; 95% confidence interval, 1.3 to 3.2). The co-existence of HTN, DYS, and ESRD with CMV diseases did not influence the IR of T2DM. Conclusion: CMV diseases increase the patients' risk of developing T2DM.

Keywords

References

  1. Kumar A, Herbein G. Epigenetic regulation of human cytomegalovirus latency: an update. Epigenomics 2014;6:533-46. https://doi.org/10.2217/epi.14.41
  2. Poole E, Sinclair J. Sleepless latency of human cytomegalovirus. Med Microbiol Immunol 2015;204:421-9. https://doi.org/10.1007/s00430-015-0401-6
  3. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol 2010;20:202-13. https://doi.org/10.1002/rmv.655
  4. Mason GM, Jackson S, Okecha G, Poole E, Sissons JG, Sinclair J, Wills MR. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4+ T cells. PLoS Pathog 2013;9:e1003635. https://doi.org/10.1371/journal.ppat.1003635
  5. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol 2005;79:11022-34. https://doi.org/10.1128/JVI.79.17.11022-11034.2005
  6. Jenkins C, Abendroth A, Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol 2004;78:1440-7. https://doi.org/10.1128/JVI.78.3.1440-1447.2004
  7. Nikolich-Zugich J, van Lier RAW. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence. Geroscience 2017;39:245-9. https://doi.org/10.1007/s11357-017-9984-8
  8. La Rosa C, Diamond DJ. The immune response to human CMV. Future Virol 2012;7:279-93. https://doi.org/10.2217/fvl.12.8
  9. Willis EL, Eberle R, Wolf RF, White GL, McFarlane D. The effects of age and cytomegalovirus on markers of inflammation and lymphocyte populations in captive baboons. PLoS One 2014;9:e107167. https://doi.org/10.1371/journal.pone.0107167
  10. Holtappels R, Pahl-Seibert MF, Thomas D, Reddehase MJ. Enrichment of immediate-early 1 (m123/pp89) peptide-specific CD8 T cells in a pulmonary CD62L(lo) memory-effector cell pool during latent murine cytomegalovirus infection of the lungs. J Virol 2000;74:11495-503. https://doi.org/10.1128/JVI.74.24.11495-11503.2000
  11. Karrer U, Sierro S, Wagner M, Oxenius A, Hengel H, Koszinowski UH, Phillips RE, Klenerman P. Memory inflation: continuous accumulation of antiviral CD8+ T cells over time. J Immunol 2003;170:2022-9. https://doi.org/10.4049/jimmunol.170.4.2022
  12. Ouyang Q, Wagner WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G. Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol 2003;23:247-57. https://doi.org/10.1023/A:1024580531705
  13. Halenius A, Hengel H. Human cytomegalovirus and autoimmune disease. Biomed Res Int 2014;2014:472978. https://doi.org/10.1155/2014/472978
  14. Ji YN, An L, Zhan P, Chen XH. Cytomegalovirus infection and coronary heart disease risk: a meta-analysis. Mol Biol Rep 2012;39:6537-46. https://doi.org/10.1007/s11033-012-1482-6
  15. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 2014;105:141-50. https://doi.org/10.1016/j.diabres.2014.04.006
  16. Grossmann V, Schmitt VH, Zeller T, Panova-Noeva M, Schulz A, Laubert-Reh D, Juenger C, Schnabel RB, Abt TG, Laskowski R, Wiltink J, Schulz E, Blankenberg S, Lackner KJ, Munzel T, Wild PS. Profile of the immune and inflammatory response in individuals with prediabetes and type 2 diabetes. Diabetes Care 2015;38:1356-64. https://doi.org/10.2337/dc14-3008
  17. Griffin SJ, Leaver JK, Irving GJ. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia 2017;60: 1620-9. https://doi.org/10.1007/s00125-017-4337-9
  18. Abdel-Moneim A, Bakery HH, Allam G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomed Pharmacother 2018;101:287-92. https://doi.org/10.1016/j.biopha.2018.02.103
  19. Szabo M, Mate B, Csep K, Benedek T. Genetic approaches to the study of gene variants and their impact on the pathophysiology of type 2 diabetes. Biochem Genet 2018;56:22-55. https://doi.org/10.1007/s10528-017-9827-4
  20. Kerru N, Singh-Pillay A, Awolade P, Singh P. Current anti-diabetic agents and their molecular targets: a review. Eur J Med Chem 2018;152:436-88. https://doi.org/10.1016/j.ejmech.2018.04.061
  21. Ashoori MR, Rahmati-Yamchi M, Ostadrahimi A, Fekri Aval S, Zarghami N. MicroRNAs and adipocytokines: promising biomarkers for pharmacological targets in diabetes mellitus and its complications. Biomed Pharmacother 2017;93:1326-36. https://doi.org/10.1016/j.biopha.2017.07.059
  22. Lohr JM, Oldstone MB. Detection of cytomegalovirus nucleic acid sequences in pancreas in type 2 diabetes. Lancet 1990;336: 644-8. https://doi.org/10.1016/0140-6736(90)92145-8
  23. Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011;332:1093-7. https://doi.org/10.1126/science.1202007
  24. Seo JY, Cresswell P. Viperin regulates cellular lipid metabolism during human cytomegalovirus infection. PLoS Pathog 2013;9: e1003497. https://doi.org/10.1371/journal.ppat.1003497
  25. Zhang J, Liu YY, Sun HL, Li S, Xiong HR, Yang ZQ, Xiang GD, Jiang XJ. High human cytomegalovirus IgG level is associated with increased incidence of diabetic atherosclerosis in type 2 diabetes mellitus patients. Med Sci Monit 2015;21:4102-10. https://doi.org/10.12659/msm.896071
  26. Chen S, de Craen AJ, Raz Y, Derhovanessian E, Vossen AC, Westendorp RG, Pawelec G, Maier AB. Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study. Immun Ageing 2012;9: 18. https://doi.org/10.1186/1742-4933-9-18
  27. Roberts BW, Cech I. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J 2005;98:686-92. https://doi.org/10.1097/01.SMJ.0000163310.12516.2D
  28. Haeseker MB, Pijpers E, Dukers-Muijrers NH, Nelemans P, Hoebe CJ, Bruggeman CA, Verbon A, Goossens VJ. Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients: a prospective cohort study. Immun Ageing 2013;10:30. https://doi.org/10.1186/1742-4933-10-30
  29. Blum A, Peleg A, Weinberg M. Anti-cytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis. Clin Exp Med 2003;3:157-60. https://doi.org/10.1007/s10238-003-0019-7
  30. Kotton CN, Kumar D, Caliendo AM, Huprikar S, Chou S, Danziger-Isakov L, Humar A; The Transplantation Society International CMV Consensus Group. The Third International Consensus Guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 2018;102:900-31. https://doi.org/10.1097/TP.0000000000002191
  31. Gomes MB, Cobas RA. Post-transplant diabetes mellitus. Diabetol Metab Syndr 2009;1:14. https://doi.org/10.1186/1758-5996-1-14
  32. Leung Ki EL, Venetz JP, Meylan P, Lamoth F, Ruiz J, Pascual M. Cytomegalovirus infection and new-onset post-transplant diabetes mellitus. Clin Transplant 2008;22:245-9. https://doi.org/10.1111/j.1399-0012.2007.00758.x
  33. Kim JA, Yoon S, Kim LY, Kim DS. Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data. J Korean Med Sci 2017;32:718-28. https://doi.org/10.3346/jkms.2017.32.5.718
  34. Liu J, Kong J, Chang YJ, Chen H, Chen YH, Han W, Wang Y, Yan CH, Wang JZ, Wang FR, Chen Y, Zhang XH, Xu LP, Liu KY, Huang XJ. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality. Clin Microbiol Infect 2015;21:1121.
  35. Lee YH, Han K, Ko SH, Ko KS, Lee KU; Taskforce Team of Diabetes Fact Sheet of the Korean Diabetes Association. Data analytic process of a nationwide population-based study using national health information database established by National Health Insurance Service. Diabetes Metab J 2016;40:79-82. https://doi.org/10.4093/dmj.2016.40.1.79
  36. Wang H, Peng G, Bai J, He B, Huang K, Hu X, Liu D. Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): a meta-analysis of prospective studies up to 2016. J Am Heart Assoc 2017;6:e005025. https://doi.org/10.1161/JAHA.116.005025
  37. American Diabetes Association. 3. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S28-37. https://doi.org/10.2337/dc18-S003
  38. Yoneda S, Imagawa A, Fukui K, Uno S, Kozawa J, Sakai M, Yumioka T, Iwahashi H, Shimomura I. A histological study of fulminant type 1 diabetes mellitus related to human cytomegalovirus reactivation. J Clin Endocrinol Metab 2017;102:2394-400. https://doi.org/10.1210/jc.2016-4029
  39. Numazaki K, Goldman H, Wong I, Wainberg MA. Viral infection of human fetal islets of Langerhans. Replication of human cytomegalovirus in cultured human fetal pancreatic islets. Am J Clin Pathol 1988;90:52-7. https://doi.org/10.1093/ajcp/90.1.52
  40. Eckhard M, Martin I, Eich T, Weimer R, Zinn S, Bretzel RG, Brendel MD. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Transplant Proc 2002;34:1922-4. https://doi.org/10.1016/S0041-1345(02)03124-X

Cited by

  1. Cytomegalovirus Disease, Short-Term Cardiovascular Events and Graft Survival in a Cohort of Kidney Transplant Recipients With High CMV IgG Seroprevalence vol.31, pp.2, 2021, https://doi.org/10.1177/15269248211002792
  2. Immunological Mechanisms of Sickness Behavior in Viral Infection vol.13, pp.11, 2021, https://doi.org/10.3390/v13112245